Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$223.55 USD
-1.06 (-0.47%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $223.49 -0.06 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$223.55 USD
-1.06 (-0.47%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $223.49 -0.06 (-0.03%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Zacks News
Marsh & McLennan (MMC) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 7.98% and 0.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Marsh & McLennan (MMC) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Marsh & McLennan's (MMC) first-quarter results are likely to reflect strength in its Consulting and Risk and Insurance Services segments.
Marsh & McLennan (MMC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Marsh & McLennan (MMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan (MMC) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Marsh & McLennan (MMC) Unit Buys Booz Allen's MENA Arm
by Zacks Equity Research
Marsh & McLennan (MMC) unit Oliver Wyman resorts to acquiring the MENA-based management consulting business of Booz Allen for strengthening MMC's capabilities and presence in the MENA region.
Marsh & McLennan (MMC) Boosts Share Buyback Program by $5B
by Zacks Equity Research
Marsh & McLennan's (MMC) strong operations, driven by its diverse product offerings, a wide geographic footprint and strong client retention, aid its efforts to enhance shareholder value.
Why Should You Hold Marsh & McLennan (MMC) in Your Portfolio?
by Zacks Equity Research
Riding high on its strategic initiatives, operational excellence and improving revenues, Marsh & McLennan (MMC) holds enough potential to reap benefits for investors.
Aon's (AON) Earnings Surpass Estimates in Q4, Surge Y/Y
by Zacks Equity Research
Aon's (AON) Q4 results reflect improved revenues as well as robust performances by its segments, namely Reinsurance Solutions, Commercial Risk Solutions and Health Solutions.
Marsh & McLennan (MMC) Q4 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter earnings benefit on the back of strong top-line growth and solid segmental contributions, partly offset by higher operating expenses.
Marsh & McLennan (MMC) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 1.49% and 4.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Why Marsh & McLennan (MMC) Might Surprise This Earnings Season
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Beat in Store for Marsh & McLennan (MMC) in Q4 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect rate increases, and solid results of Risk and Insurance Services and Consulting segments, partly offset by higher costs.
What Awaits Arthur J. Gallagher (AJG) This Earnings Season?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) fourth-quarter results are expected to reflect higher demand for consulting services, improvement in covered lives on renewal business and higher renewal exposure units.
MarketAxess (MKTX) Gears Up for Q4 Earnings: What to Expect
by Zacks Equity Research
MarketAxess' (MKTX) fourth-quarter results are likely to be affected by lower transaction fees.
Marsh & McLennan (MMC) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Marsh & McLennan (MMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Insurers Set to Surpass Expectations This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help RE, AEL, AFL, MMC, and AIG outperform Q4 earnings estimates.
Marsh & McLennan (MMC) Unit Unveils Digital Platform in Asia Pacific
by Zacks Equity Research
Marsh & McLennan (MMC) unit Oliver Wyman launches Edge for helping incumbent banks, tech firms and new entrants of the Asia Pacific region with enhanced digital capabilities.
Why Should You Add Marsh & McLennan (MMC) in Your Portfolio?
by Zacks Equity Research
Riding high on an enhanced portfolio and strategic initiatives, Marsh & McLennan (MMC) emerges as an attractive investment bet.
Why Discover Financial (DFS) is Likely to Post Q4 Earnings Beat
by Zacks Equity Research
Discover Financial's (DFS) fourth-quarter results are likely to reflect improved sales volume and new account growth.
Here's Why Buying Brown and Brown (BRO) Stock Seems Prudent
by Zacks Equity Research
Improving new business, solid retention and continued rate increases for most lines of coverage should drive growth for Brown and Brown (BRO).
Marsh & McLennan (MMC) Arm Sells Associations Business to AMBA
by Zacks Equity Research
Marsh & McLennan (MMC) arm Mercer's divestment of Associations business is likely to close in the second quarter of this year.
Should You Retain eHealth (EHTH) Stock in Your Portfolio?
by Zacks Equity Research
eHealth (EHTH) continues to benefit from growth in Medicare Advantage plan members, higher commission revenues and higher internal agent productivity.
Zacks Industry Outlook Highlights: Marsh & McLennan Companies, Arthur J. Gallagher, Willis Tower Watson plc, Brown & Brown and Ryan Specialty Group Holdings
by Zacks Equity Research
Marsh & McLennan Companies, Arthur J. Gallagher, Willis Tower Watson plc, Brown & Brown and Ryan Specialty Group Holdings are included in this industry outlook blog.
5 Insurance Brokers That Continue to Benefit From Increasing Demand
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials and adoption of technology should drive Insurance Brokers like MMC, AJG, WLTW, BRO and RYAN.
Marsh & McLennan (MMC) Arm Increases Stake in Indian Unit
by Zacks Equity Research
Marsh & McLennan's (MMC) Marsh unit hikes share in Marsh India to 92% to help firms in India handle recent challenges.